secwatch.observer — SEC 8-K summary
======================================

Issuer:     1606 CORP. (CBDW)
CIK:        0001877461
Form:       8-K
Filed at:   2024-09-04T23:59:59+00:00
Accession:  0001477932-24-005466
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.45
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

1606 Corp. signs non-binding LOI to acquire strategic stake in AI biotech Adnexus
--------------------------------------------------------------------------------

- LOI for a strategic stake in Adnexus, an AI biotech focused on early drug discovery and infectious disease research.
- Adnexus develops fully human monoclonal antibodies using immune B-cells from recovered HIV and SARS-COV-2 patients.
- Transaction subject to customary due diligence and conditions; no deal value or stake percentage disclosed.
- CEO Austen Lambrecht states the partnership aligns with expanding AI capabilities in healthcare.
- 1606 Corp. (OTC Pink: CBDW) will present at the 150th NIBA Show in Fort Lauderdale on August 5, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1877461/000147793224005466/0001477932-24-005466-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1877461/000147793224005466/cbdw_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-24-005466

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer